Peer-reviewedLicence not statedThe Lancet
Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)
22 affiliations
- 1Renal and Metabolic Division, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Department of Renal Medicine, Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: [email protected]
- 2Renal and Metabolic Division, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
- 3University of New South Wales, Sydney, NSW, Australia
- 4Division of Nephrology, University Health Network, Toronto General Hospital, University of Toronto, Toronto, ON, Canada
- 5National Heart Centre Singapore, Singapore; Duke-National University of Singapore Medical School, Singapore
- 6Providence Inland Northwest Health, University of Washington School of Medicine, Spokane, WA, USA
- 7Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany
- 81(st) Department of Nephrology, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece
- 9Department of Cardiology of German Heart Center Charité, German Centre for Cardiovascular Research partner site Berlin, Charité Universitätsmedizin, Berlin, Germany
- 10National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Athens, Greece
- 11Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA
- 12Steno Diabetes Center Copenhagen, Herlev, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
- 13Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain; CIBER Cardiovascular, Hospital Universitario 12 de Octubre, Madrid, Spain; Faculty of Sport Sciences, European University of Madrid, Madrid, Spain
- 14Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
- 15Cardiology and Nephrology Clinical Development, Bayer, Wuppertal, Germany
- 16Clinical Statistics & Analytics, Bayer, Berlin, Germany
- 17Cardiology and Nephrology Clinical Development, Bayer, São Paulo, Brazil
- 18Medical Affairs and Pharmacovigilance, Pharmaceuticals, Bayer, Wuppertal, Germany
- 19Model-Informed Drug Development, Pharmaceuticals R&D, Bayer, Leverkusen, Germany
- 20Global Medical & Evidence CV and Heme, Bayer, Berlin, Germany; Children's University Hospital, University Hospital Regensburg, Regensburg, Germany
- 21Cardiology and Nephrology Clinical Development, Bayer, Berlin, Germany
- 22Division of Nephrology, Richard L Roudebush VA Medical Center, Indianapolis, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: [email protected]
Related
- Vitamin D supplementation to prevent tuberculosis infection and disease: systematic review and individual participant data meta-analysis of randomised controlled trials
- Intravascular imaging-guided versus angiography-guided percutaneous coronary intervention: a reconstructed individual participant data meta-analysis of randomized controlled trials of intravascular ultrasound- and optical coherence tomography-guided strategies
- Omega‐6 Polyunsaturated Fatty Acids and Peripheral Artery Disease: An Individual Participant‐Level Analysis of 9 International Prospective Studies
- Pooling individual off-pump and on-pump coronary artery bypass patient records from three contemporary multicenter, randomized, controlled trials: an individual participant data meta-analysis protocol
- Identifying eating behaviour phenotype cut-off scores for childhood obesity: an individual participant data meta-analysis using the Child Eating Behaviour Questionnaire (CEBQ)
BibTeX
@article{neuen2026efficacy,
title = {{Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)}},
author = {Brendon Lange Neuen and Hiddo J.L. Heerspink and Vlado Perkovic and David Z.I. Cherney and Carolyn S.P. Lam and Katherine R. Tuttle and Christoph Wanner and Pantelis A. Sarafidis and Stefan D. Anker and Gerasimos S Filippatos and Bertram Pitt and Peter R Rossing and Luis Miguel Ruilope and Niels Jongs and Johannes David Smeijer and MEIKE DANIELA BRINKER and Christiane Ahlers and Andrea Z. Lage and Andrea Horvat-Broecker and Patrick Schloemer and Thomas Eißing and Rania Dayoub and Robert Lawatscheck and Rajiv Agarwal},
journal = {The Lancet},
year = {2026},
month = jun,
doi = {10.1016/s0140-6736(26)01009-3},
url = {https://research.rug.nl/en/publications/5cad4392-fb74-473f-b1ef-379247d63db0},
}
RIS
TY - JOUR
TI - Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)
AU - Brendon Lange Neuen
AU - Hiddo J.L. Heerspink
AU - Vlado Perkovic
AU - David Z.I. Cherney
AU - Carolyn S.P. Lam
AU - Katherine R. Tuttle
AU - Christoph Wanner
AU - Pantelis A. Sarafidis
AU - Stefan D. Anker
AU - Gerasimos S Filippatos
AU - Bertram Pitt
AU - Peter R Rossing
AU - Luis Miguel Ruilope
AU - Niels Jongs
AU - Johannes David Smeijer
AU - MEIKE DANIELA BRINKER
AU - Christiane Ahlers
AU - Andrea Z. Lage
AU - Andrea Horvat-Broecker
AU - Patrick Schloemer
AU - Thomas Eißing
AU - Rania Dayoub
AU - Robert Lawatscheck
AU - Rajiv Agarwal
PY - 2026
DA - 2026/06/01
JO - The Lancet
DO - 10.1016/s0140-6736(26)01009-3
UR - https://research.rug.nl/en/publications/5cad4392-fb74-473f-b1ef-379247d63db0
SN - 0099-5355
SN - 0140-6736
SN - 1474-547X
ER -